XML 18 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows From Operating Activities:    
Net income (loss) $ (474,440) $ (391,303)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization expense 277,562 215,675
Amortization of loan discount 21,120 23,413
Accretion of asset retirement obligation 1,537 1,447
Common stock payable for directors fees 43,750 43,750
Foreign exchange loss 50,000 41,451
Other, net (444) (426)
Change in:    
Accounts receivable, net (49,967) (2,261)
Inventories 273,615 (55,386)
Other current assets 4,697 17,918
IVA receivable and other assets (45,609) (48,167)
Accounts payable 16,202 324,508
Accrued payroll, taxes and interest 10,015 (20,415)
Other accrued liabilities 27,271 5,886
Deferred revenue 116 0
Payables to related parties 8,236 (12,477)
Net cash provided (used) by operating activities 163,661 143,613
Cash Flows From Investing Activities:    
Purchase of properties, plants and equipment (94,805) (79,599)
Net cash used by investing activities (94,805) (79,599)
Cash Flows From Financing Activities:    
Change in checks issued and payable (17,203) (21,519)
Net proceeds from (payments to) factor 1,870 (4,388)
Advance from related party 75,000 0
Proceeds from note payable to bank 0 15,985
Principal payments on notes payable to bank (95,448) 0
Principal payments on long-term debt (48,681) (53,020)
Net cash provided (used) by financing activities (84,462) (62,942)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (15,606) 1,072
Cash and cash equivalents at beginning of period 91,332 73,331
Cash and cash equivalents at end of period 75,726 74,403
Noncash investing and financing activities:    
Common stock payable issued to directors $ 0 $ 168,750